Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00661414 | Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors(ASONEP) | completed | Phase 1 | 37 | Lpath, Inc.INDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00949624 | CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors | completed | Phase 1 | 50 | Arog Pharmaceuticals, Inc.INDUSTRY | 2 | Jan 19, 2012 | clinicaltrials |
| NCT01028859 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | completed | Phase 1 | 30 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Dec 22, 2011 | clinicaltrials |
| NCT00069264 | Study of E7389 in Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | Eisai Inc.INDUSTRY | 1 | Dec 20, 2011 | clinicaltrials |
| NCT01491204 | Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer | completed | Phase 1 | 25 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 0 | Dec 13, 2011 | clinicaltrials |
| NCT00935844 | Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 20 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00831896 | Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies | completed | Phase 1 | 27 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 2, 2011 | clinicaltrials |
| NCT00697879 | Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours | completed | Phase 1 | 40 | Chroma TherapeuticsINDUSTRY | 2 | Nov 28, 2011 | clinicaltrials |
| NCT01401933 | Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 14 | AbbottINDUSTRY | 1 | Nov 2, 2011 | clinicaltrials |
| NCT00977210 | Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | Mateon TherapeuticsINDUSTRY | 1 | Oct 31, 2011 | clinicaltrials |
| NCT00524524 | An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors | completed | Phase 1 | 9 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Oct 19, 2011 | clinicaltrials |
| NCT00825487 | Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies | completed | Phase 1 | 50 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Oct 19, 2011 | clinicaltrials |
| NCT01141257 | Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study Drug | completed | Phase 1 | 26 | Pieris Pharmaceuticals GmbHINDUSTRY | 1 | Oct 19, 2011 | clinicaltrials |
| NCT00785941 | A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available | completed | Phase 1 | 16 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT00513851 | Phase 1 Study of OSI-930 in Cancer Patients | completed | Phase 1 | 60 | Astellas Pharma IncINDUSTRY | 2 | Sep 27, 2011 | clinicaltrials |
| NCT00603356 | Phase I Study of OSI-930 and Erlotinib in Cancer Tumors | completed | Phase 1 | 60 | Astellas Pharma IncINDUSTRY | 2 | Sep 27, 2011 | clinicaltrials |
| NCT01210846 | A Cardiac Safety Study of Tivozanib to Evaluate the Electrocardiogram and Pharmacokinetic-Electrocardiogram Dynamics in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 26, 2011 | clinicaltrials |
| NCT01253837 | L19TNFα in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT00541138 | Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors | completed | Phase 2 | 50 | City of Hope Medical CenterOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT01062620 | A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer | completed | Phase 1 | 49 | Axelar ABINDUSTRY | 1 | Sep 15, 2011 | clinicaltrials |
| NCT00882180 | Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement | completed | Phase 1 | 41 | Alnylam PharmaceuticalsINDUSTRY | 2 | Aug 24, 2011 | clinicaltrials |
| NCT00611468 | Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors | completed | Phase 1 | 29 | Accelerated Community Oncology Research NetworkOTHER | 1 | Aug 22, 2011 | clinicaltrials |
| NCT00982267 | A Trial Of SU14813 In Patients With Advanced Solid Malignancies | completed | Phase 1 | 77 | PfizerINDUSTRY | 2 | Aug 8, 2011 | clinicaltrials |
| NCT00003038 | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00003690 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00004075 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00005068 | Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00006362 | PS-341 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00502567 | A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors | completed | Phase 1 | 104 | AstraZenecaINDUSTRY | 1 | Jul 27, 2011 | clinicaltrials |
| NCT01114191 | A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869) | completed | Phase 1 | 12 | AbbottINDUSTRY | 1 | Jul 26, 2011 | clinicaltrials |
| NCT01386866 | Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors | completed | Phase 1 | 4 | AmgenINDUSTRY | 0 | Jul 15, 2011 | clinicaltrials |
| NCT00401180 | Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer | completed | Phase 1 | 25 | The Cleveland ClinicOTHER | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00415116 | Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 14 | The Cleveland ClinicOTHER | 0 | Jul 8, 2011 | clinicaltrials |
| NCT01151384 | Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors(LE-DT) | completed | Phase 1 | 30 | INSYS Therapeutics IncINDUSTRY | 1 | Jul 4, 2011 | clinicaltrials |
| NCT00768391 | Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available | completed | Phase 1 | 20 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00973076 | Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055 | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00658970 | Evaluation of KX2-391 in Patients With Advanced Malignancies | completed | Phase 1 | 50 | Athenex, Inc.INDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00788099 | Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 45 | PharmaMarINDUSTRY | 2 | Jun 7, 2011 | clinicaltrials |
| NCT00616213 | PR104 and G-CSF in Treating Patients With Solid Tumors | completed | Phase 1 | 5 | Proacta, IncorporatedINDUSTRY | 2 | Jun 1, 2011 | clinicaltrials |
| NCT01358227 | A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors | completed | Phase 1 | 26 | Proacta, IncorporatedINDUSTRY | 1 | May 24, 2011 | clinicaltrials |
| NCT00661999 | Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer | completed | Phase 3 | 502 | Mayo ClinicOTHER | 1 | May 17, 2011 | clinicaltrials |
| NCT00559195 | Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors | completed | Phase 2 | 40 | Centre Hospital Regional Universitaire de LimogesOTHER | 1 | May 16, 2011 | clinicaltrials |
| NCT00704366 | AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours | completed | Phase 1 | 18 | AstraZenecaINDUSTRY | 1 | May 16, 2011 | clinicaltrials |
| NCT00770172 | G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy | completed | Phase 3 | 140 | Centre Francois BaclesseOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00002504 | Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00002505 | Tumor Cell Vaccine in Treating Patients With Advanced Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00002733 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | 30 | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00046904 | Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer | completed | Phase 3 | — | Mayo ClinicOTHER | 1 | May 5, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jan 31, 2012source: clinicaltrials